Niraparib (Zejula®) accepted for use within NHSScotland

This is recommended as monotherapy for maintenance treatment of adult patients with advanced epithelial (FIGO Stages III or IV) high-grade ovarian, fallopian tube or primary peritoneal cancer who have responded to first-line platinum-based chemotherapy.

Scottish Medicines Consortium